Heparin-induced thrombocytopenia: An update

被引：89

作者：

Franchini M. ^{[1
,2
]}

机构：

[1] Servizio di Immunoematologia e Trasfusione, Azienda Ospedaliera di Verona, Verona

[2] Servizio di Immunoematologia e Trasfusione, Ospedale Policlinico, 37134 Verona

来源：

Thrombosis Journal | / 3卷 / 1期

关键词：

Heparin; Platelets; Thrombosis;

D O I：

10.1186/1477-9560-3-14

中图分类号：

学科分类号：

摘要：

Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized. In this review, we briefly discuss the main features of heparin-induced thrombocytopenia, particularly analyzing the most recent advances in the pathophysiology, diagnosis and treatment of this syndrome. © 2005 Franchini; licensee BioMed Central Ltd.

引用

页数：19

共 53 条

[31]

Warkentin T.E., Heparin-induced skin lesions, Br. J. Haematol., 92, pp. 494-497, (1996)

[32]

Klein H.G., Bell W.R., Disseminated intravascular coagulation during heparin therapy, Ann. Intern. Med., 80, pp. 477-481, (1974)

[33]

Alving B.M., How I treat heparin-induced thrombocytopenia and thrombosis, Blood, 101, pp. 31-37, (2003)

[34]

Wallis D.E., Workman D.L., Lewis B.E., Steen L., Pifarre R., Moran J.F., Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia, Am. J. Med., 106, pp. 629-635, (1999)

[35]

Chong B.H., Diagnosis, treatment and pathophysiology of immune-mediated thrombocytopenia, Crit. Rev. Oncol. Hematol., 20, pp. 271-296, (1995)

[36]

Magnani H.N., Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with orgaran (Org 10172), Thromb. Haemost., 70, pp. 554-561, (1993)

[37]

Greinacher A., Janssens U., Berg G., Et al., Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia, Circulation, 100, pp. 587-593, (1999)

[38]

Greinacher A., Volpel H., Janssens U., Et al., Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: A prospective study, Circulation, 99, pp. 73-80, (1999)

[39]

Greinacher A., Eichler P., Lubenow N., Kwasny H., Luz M., Heparin-induced thrombocytopenia with thromboembolic complications: Meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range, Blood, 96, pp. 846-851, (2000)

[40]

Lewis B.E., Wallis D.E., Berkowitz S.D., Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia, Circulation, 103, pp. 1838-1843, (2001)

← 1 2 3 4 5 6 →